Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Pediatr Infect Dis J ; 40(10): e364-e369, 2021 10 01.
Article in English | MEDLINE | ID: mdl-34260501

ABSTRACT

BACKGROUND: To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). METHODS: Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic patterns, surgical treatment and intraoperative findings, outcomes. FINDINGS: One-thousand ten children were enrolled. Forty-two children (4.2%) had a clinical diagnosis of acute abdomen. Four (9.5%) were diagnosed with MIS-C and did not undergo surgery. The remaining 38 children (3.8%) underwent abdominal surgery due to suspected appendicitis, 34 of them (89.7%) had an intraoperative diagnosis of acute appendicitis (AA), while 4 of them had nonsurgical findings. Eight children died (0.8%), none of them being diagnosed with appendicitis. Children with AA were significantly older than those without (P < 0.0001). Children with complicated appendicitis had more frequently fever (85.7% vs. 60%), intestinal distension on the abdominal radiograph (7.1% vs. none), leukocytosis (85.7% vs. 40%) and high levels of C-reactive protein (35.7% vs. 5%), although differences were not statistically significant. CONCLUSIONS: Our study showed that children may present with acute abdomen during COVID-19 or MIS-C, which is not always associated with intraoperative findings of appendicitis, particularly in case of MIS-C. Further studies are needed to better characterize children with acute abdomen during COVID-19 or MIS-C, to avoid delay in diagnosis of surgical conditions and at the same time, minimize unnecessary surgical approaches.


Subject(s)
Abdomen, Acute/etiology , Abdomen, Acute/virology , Appendicitis/etiology , Appendicitis/virology , COVID-19/complications , Systemic Inflammatory Response Syndrome/etiology , Systemic Inflammatory Response Syndrome/virology , Adolescent , COVID-19/etiology , COVID-19/virology , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Latin America , Male , SARS-CoV-2/pathogenicity
2.
Acta Paediatr ; 110(6): 1902-1910, 2021 06.
Article in English | MEDLINE | ID: mdl-33742466

ABSTRACT

AIM: This study aims to assess rates of antibiotic prescriptions and its determinants in in children with COVID-19 or Multisystem Inflammatory Syndrome (MIS-C). METHODS: Children <18 years-old assessed in five Latin Americas countries with a diagnosis of COVID-19 or MIS-C were enrolled. Antibiotic prescriptions and factors associated with their use were assessed. RESULTS: A total of 990 children were included: 921 (93%) with COVID-19, 69 (7.0%) with MIS-C. The prevalence of antibiotic use was 24.5% (n = 243). MIS-C with (OR = 45.48) or without (OR = 10.35) cardiac involvement, provision of intensive care (OR = 9.60), need for hospital care (OR = 6.87), pneumonia and/or ARDS detected through chest X-rays (OR = 4.40), administration of systemic corticosteroids (OR = 4.39), oxygen support, mechanical ventilation or CPAP (OR = 2.21), pyrexia (OR = 1.84), and female sex (OR = 1.50) were independently associated with increased use of antibiotics. There was significant variation in antibiotic use across the hospitals. CONCLUSION: Our study showed a high rate of antibiotic prescriptions in children with COVID-19, in particular in those with severe disease or MIS-C. Prospective studies are needed to provide better evidence on the recognition and management of bacterial infections in COVID-19 children.


Subject(s)
COVID-19 , Adolescent , Anti-Bacterial Agents/therapeutic use , Child , Female , Humans , Latin America/epidemiology , Prescriptions , Prospective Studies , SARS-CoV-2 , Systemic Inflammatory Response Syndrome
3.
Pediatr Infect Dis J ; 40(1): e1-e6, 2021 01.
Article in English | MEDLINE | ID: mdl-33055501

ABSTRACT

BACKGROUND: To date, there are no comprehensive data on pediatric COVID-19 from Latin America. This study aims to assess COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) in Latin American children, to appropriately plan and allocate resources to face the pandemic on a local and international level. METHODS: Ambispective multicenter cohort study from 5 Latin American countries. Children 18 years of age or younger with microbiologically confirmed SARS-CoV-2 infection or fulfilling MIS-C definition were included. FINDINGS: Four hundred nine children were included, with a median age of 3.0 years (interquartile range 0.6-9.0). Of these, 95 (23.2%) were diagnosed with MIS-C. One hundred ninety-one (46.7%) children were admitted to hospital and 52 (12.7%) required admission to a pediatric intensive care unit. Ninety-two (22.5%) patients required oxygen support: 8 (2%) were started on continuous positive airway pressure and 29 (7%) on mechanical ventilation. Thirty-five (8.5%) patients required inotropic support. The following factors were associated with pediatric intensive care unit admission: preexisting medical condition (P < 0.0001), immunodeficiency (P = 0.01), lower respiratory tract infection (P < 0.0001), gastrointestinal symptoms (P = 0.006), radiologic changes suggestive of pneumonia and acute respiratory distress syndrome (P < 0.0001) and low socioeconomic conditions (P = 0.009). CONCLUSIONS: This study shows a generally more severe form of COVID-19 and a high number of MIS-C in Latin American children, compared with studies from China, Europe and North America, and support current evidence of a more severe disease in Latin/Hispanic children or in people of lower socioeconomic level. The findings highlight an urgent need for more data on COVID-19 in Latin America.


Subject(s)
COVID-19/epidemiology , COVID-19/pathology , Systemic Inflammatory Response Syndrome/epidemiology , Systemic Inflammatory Response Syndrome/pathology , Adolescent , COVID-19/diagnosis , COVID-19/therapy , Child , Child, Preschool , Cohort Studies , Critical Care , Female , Hospitalization , Humans , Infant , Infant, Newborn , Latin America/epidemiology , Male , Risk Factors , SARS-CoV-2/isolation & purification , Systemic Inflammatory Response Syndrome/diagnosis , Systemic Inflammatory Response Syndrome/therapy
4.
s.l; UPCH. Facultad de Medicina Alberto Hurtado; 1991. 72 p. (PE-4025-4025a).
Thesis in Spanish | LILACS | ID: lil-107401

ABSTRACT

La morbilidad infecciosa post-operatoria es la principal complicación de la cirugía vaginal. Se realizó un estudio retrospectivo con el fin de evaluar la incidencia de esta complicación y analizar la influencia del drenaje vesial trans-uretral permanente en dicha morbilidad. Se estudiaron 150 pacientes clasificados en 2 grupos: Grupo A con 43 pacientes en las que no se empleó drenaje vesical permanente luego de la cirugía y Grupo B con 107 pacientes en quienes se instaló sonda trans-uretral permanente durante el post-operatorio. La tasa de morbilidad infecciosa en el Grupo A fue 23.3 por ciento y en el Grupo B fue 57.9 por ciento (p menor de 0.001). La complicación infecciosa más frecuente fue la infección urinaria. En el Grupo A fue 7 por ciento y en el grupo B fue 29 por ciento (p menor de 0.01). El germen más frecuentemente aislado fue E. coli en el 50 por ciento de los casos. No hubo diferencia significativa entre la tasa de retención urinaria de las pacientes del Grupo A (18.6 por ciento) y las pacientes del grupo B (24.3 por ciento). Soló en el 11.6 por ciento de pacientes del Grupo A fue necesaria la instalación de una sonda permanente por presentar retención urinaria persistente. Los hallazgos del presente estudio sugieren que el manejo post-operatorio sin sonda puede ser una alternativa para la disminución de las complicaciones infecciosas en este tipo de cirugía


Subject(s)
Humans , Female , Catheters, Indwelling/adverse effects , Postoperative Complications/mortality , Urinary Tract Infections/etiology , Uterine Prolapse/surgery , Peru , Retrospective Studies , Time Factors , Urinary Tract Infections/mortality
SELECTION OF CITATIONS
SEARCH DETAIL
...